Showing 3331-3340 of 5621 results for "".
- iVeena Doses First Participant in Phase 1 Trial of IVMED-85 for Myopia Progressionhttps://modernod.com/news/iveena-doses-first-participant-in-phase-1-trial-of-ivmed-85-for-myopia-progression/2485668/iVeena Delivery Systems announced that the first patient has been dosed in its phase 1, first-in-human clinical study of IVMED-85 in healthy adult volunteers. The phase 1 trial is designed to evaluate the safety and tolerabili
- Alcon Launches PRECISION7 Weekly Contact Lenses in Canadahttps://modernod.com/news/alcon-launches-precision7-weekly-contact-lenses-in-canada/2485580/Key Takeaways PRECISION7 is the only 1-week replacement contact lens with the ACTIV-FLO System, deliverin
- China’s NMPA Approves Zeiss Artevo 750 and Artevo 850 Ophthalmic Microscopeshttps://modernod.com/news/chinas-nmpa-approves-zeiss-artevo-750-and-artevo-850-ophthalmic-microscopes/2485563/Zeiss announced that China’s National Medical Products Administration (NMPA) has approved the Zeiss Artevo 750 and Zeiss Artevo 850 ophthalmic microscopes. Designed to support both anterior and posterior segment procedures, th
- Orasis Pharmaceuticals Presents New Data Showing Qlosi Is Pupil Selective in Presbyopic Eyeshttps://modernod.com/news/orasis-pharmaceuticals-presents-new-data-showing-qlosi-is-pupil-selective-in-presbyopic-eyes/2485470/Orasis Pharmaceuticals announced new clinical data demonstrating that Qlosi (pilocarpine hydrochloride ophthalmic solution) 0.4% is pupil selective, significantly reducing pupil diameter without a statistically significant change in ciliary muscle response in presb
- Tickets and Sponsorships Available for 2026 Prevent Blindness Person of Vision Award Gala Honoring Jim McGrannhttps://modernod.com/news/tickets-and-sponsorships-available-for-2026-prevent-blindness-person-of-vision-award-gala-honoring-jim-mcgrann/2485427/Prevent Blindness has announced that tickets and sponsorship opportunities remain available for the 2026 Prevent Blindness Person of Vision Award gala, which will honor Jim McGrann, CEO of Advancing Eyecare, for his decades of leadership and dedication to improving
- Focus Vitamins Launches Preservative-Free Artificial Tears to Address Rising Eye Drynesshttps://modernod.com/news/focus-vitamins-launches-preservative-free-artificial-tears-to-address-rising-eye-dryness/2485384/Focus Vitamins announced the launch of Focus Tears PF Eye Drops, a new preservative-free artificial tear designed to provide fast, soothing relief for dry, irritated eyes. The new product is formulated to address common symptom
- Orbis International Appoints Kathleen Sherwin as New President and CEOhttps://modernod.com/news/orbis-international-appoints-kathleen-sherwin-as-new-president-and-ceo/2485326/Global nonprofit organization Orbis International has named Kathleen Sherwin as its new President and Chief Executive Officer, effective immediately. Ms. Sherwin arrives at Orbis with more than 25 years of leadership experience
- AptarGroup Highlights New “Beat the Blink” Technologyhttps://modernod.com/news/aptargroup-highlights-new-beat-the-blink-technology/2485307/AptarGroup shared an overview of its portfolio of eye care solutions, including 'Beat the Blink,' a new eye care delivery system designed to improve dosing accuracy and enhance the patient experience by “beating the blink” reflex. The technology is currently part of
- Nanodropper Now Operating as Mu Medical Under New Consolidation Planhttps://modernod.com/news/nanodropper-now-operating-as-mu-medical-under-new-consolidation-plan/2485284/Nanodropper, provider of micro-volume ophthalmic delivery technology, announced that Bedo Solutions and Viseon Labs have agreed on terms to join its eyecare platform under a new corporate identity, Mu Medical. Financial terms of the deal were not disclosed.
- New International Myopia Guidance Urges Early, Personalized Carehttps://modernod.com/news/new-international-myopia-guidance-urges-early-personalized-care/2485288/The International Myopia Institute (IMI) has published its 2025 Digest, delivering the latest evidence-based guidance on myopia. The Dige